Opens in a new tab

Restless Legs Syndrome: Causes, Iron Tests and Treatment

Table of Content

Friendly doctor talking with a smiling adult patient sitting on a sofa with a blanket over the legs, with blood test tubes, a ferritin lab report and a glass of water on a bedside table

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

Restless legs syndrome (RLS), also called Willis-Ekbom disease, is a nervous system and sleep disorder that causes a strong urge to move your legs, usually with uncomfortable feelings such as crawling, pulling, aching or tingling. The urge starts or gets worse when you sit or lie still, eases when you move, and is worst in the evening or at night. About 8% of US adults have some symptoms each year, and about 3% have moderate or severe symptoms at least twice a week.

The most common treatable cause is low iron, even when you are not anaemic. Every person with troublesome RLS should have morning iron studies, including ferritin and transferrin saturation. The 2025 American Academy of Sleep Medicine (AASM) guideline now puts gabapentinoids and intravenous (IV) iron first, and advises against the routine use of dopamine agonists such as pramipexole and ropinirole, because over time they can make RLS worse.

Key takeaways

  • RLS is diagnosed from your story: an urge to move, worse at rest, relieved by movement, worse in the evening, and not explained by another condition. No scan or sleep study is needed to confirm it.
  • Iron matters most: iron treatment is advised when ferritin is 75 ng/mL or lower or transferrin saturation is below 20%, and IV iron when ferritin is 75 to 100 ng/mL. These cutoffs are higher than the usual cutoffs for iron deficiency.
  • First-line medicines are gabapentin, gabapentin enacarbil and pregabalin. Dopamine agonists can cause augmentation, a drug-induced worsening of RLS.
  • RLS is common in pregnancy, kidney failure, iron deficiency anaemia, neuropathy, multiple sclerosis and Parkinson's disease, and it can affect children.

What is restless legs syndrome?

RLS is a sensorimotor disorder: it affects both what you feel and how you move. MedlinePlus describes it as an unstoppable urge to get up and pace or walk, with discomfort that only stops while you keep moving. The Sleep Foundation adds that most people feel the sensations deep in the legs, most often between the knee and the ankle, and that they can sometimes affect the arms.

"Restless legs syndrome" and "Willis-Ekbom disease" mean the same condition. The 2026 JAMA review by Winkelman and Wipper estimates that RLS is clinically significant in about 3% of US adults, and in 10% of adults aged 65 and older. Women are affected about twice as often as men.

Cleveland Clinic separates two forms. Early-onset (primary or idiopathic) RLS starts before age 45, often runs in families and progresses slowly. Late-onset (secondary) RLS starts after 45, progresses faster and is more often linked to another condition such as kidney disease or iron deficiency.

Restless leg syndrome causes and risk factors

The exact cause is not fully known, but the main mechanism is now well described: too little iron inside the brain. A 2024 review in Medicina Clinica explains that genes, environment and other diseases combine to lower brain iron, which then disturbs dopamine, adenosine and glutamate signaling. Cleveland Clinic notes that brain iron can be low even when your blood iron looks normal, which is why doctors use higher ferritin targets in RLS.

Genes and family history

MedlinePlus Genetics reports that 40 to 90% of people with RLS have at least one affected parent, brother, sister or child. Several gene variants raise the risk, many of them involved in nerve development before birth, but each one explains only a small part of it.

Conditions linked to RLS

According to the JAMA review, RLS is much more common in some groups:

MedlinePlus adds diabetes, and deficiencies of iron, magnesium or folic acid, to the list of linked conditions.

Triggers you can change

The AASM lists the factors to address first: alcohol, caffeine, medicines with antihistamine, serotonergic or antidopaminergic effects, and untreated obstructive sleep apnoea. The JAMA review names centrally acting antihistamines such as diphenhydramine, serotonergic antidepressants and dopamine-blocking drugs. MedlinePlus also mentions calcium channel blockers, lithium, neuroleptics (antipsychotics), nicotine and stopping sedatives. Never stop a prescribed drug on your own: ask your doctor whether there is an alternative. If you snore or stop breathing at night, read our guide to sleep apnoea symptoms, tests and treatment.

Symptoms of restless legs syndrome

People describe the feelings in many ways: creeping, crawling, pulling, tugging, burning, aching, throbbing, itching or "pins and needles". MedlinePlus notes that they often last an hour or longer and make it hard to sit through a flight, a long car ride, a class or a meeting. Stress can make them worse.

The main consequence is poor sleep. RLS delays falling asleep and wakes you during the night, which leads to daytime sleepiness, low mood, anxiety and trouble concentrating. The JAMA review reports higher rates of depression (30.4%) and cardiovascular disease among people with RLS. If low mood lasts, our article on depression symptoms and diagnosis can help you prepare a visit.

Periodic limb movements

Cleveland Clinic estimates that 8 to 9 in 10 people with RLS also have periodic limb movements of sleep (PLMS): repeated jerks of the legs, sometimes the arms, while asleep. You may not notice them, but a bed partner often does.

What RLS is not

Several conditions look similar. Night-time leg cramps cause a hard, painful muscle knot rather than an urge to move; see our article on hamstring cramps and their relief. Neuropathy causes burning, numbness or tingling that does not improve with walking. Discomfort from an awkward position goes away after a simple change of position. In children, a 2025 review lists growing pains, leg cramps and positional discomfort among the common mimics.

How is restless legs syndrome diagnosed?

RLS is a clinical diagnosis. Cleveland Clinic lists the criteria your clinician checks:

  1. an urge to move the legs, usually with unpleasant sensations;
  2. symptoms that begin or worsen during rest or inactivity;
  3. partial or total relief with walking, stretching or exercise;
  4. symptoms worse in the evening or at night;
  5. symptoms not explained by another medical or behavioural condition.

The JAMA review states that a sleep study (polysomnography) is not recommended to diagnose RLS. It may still be used to look for sleep apnoea or another sleep disorder.

Blood tests for restless legs

The AASM says that all patients with clinically significant RLS should regularly have iron studies:

  • ferritin, the protein that stores iron and reflects your iron reserves;
  • serum iron and total iron-binding capacity (TIBC), used to calculate the transferrin saturation (TSAT);
  • usually a complete blood count to look for anaemia.

Timing matters. The guideline advises a morning blood draw, with no iron supplements and no iron-containing foods for at least 24 hours beforehand, because recent iron raises serum iron for a while and can make TSAT look better than it is. Our guide to the iron studies panel, ferritin and TIBC explains how these values fit together.

Your doctor may add other tests depending on your history: kidney function, blood sugar or HbA1c if neuropathy is suspected, vitamin B12 and folate, and a pregnancy test when relevant. Ferritin also rises with inflammation, as a 2024 paediatric review reminds, so a "normal" ferritin can hide low iron. In that case TSAT is especially useful.

Ferritin and iron thresholds in restless legs syndrome

For RLS, doctors aim for higher iron stores than for anaemia. A ferritin of 50 ng/mL may be "normal" on your lab report but still low for restless legs. Ferritin in ng/mL has the same number in µg/L (the SI unit). TSAT is a percentage in both systems.

Result (ng/mL / µg/L)WhoWhat the guidance suggests
Ferritin 75 ng/mL or lower (75 µg/L), or TSAT below 20%Adults with RLSOral or IV iron (AASM good practice statement)
Ferritin 75 to 100 ng/mL (75-100 µg/L)Adults with RLSIV iron only (AASM)
Ferritin 100 ng/mL or lower, or TSAT below 20%Adults with RLSStart ferrous sulfate 325-650 mg daily or every other day, or IV iron 1,000 mg (JAMA review, 2026)
Ferritin below 300 ng/mL (300 µg/L)Adults with moderate to severe RLSFerric carboxymaltose 1,000 mg shown effective (IRLSSG task force, 2018)
Ferritin below 200 ng/mL and TSAT below 20%Adults on dialysis (end-stage kidney disease)IV iron sucrose suggested (AASM)
Ferritin below 50 ng/mL (50 µg/L)Children with RLSOral or IV iron (AASM)

How to read your results

A ferritin under 30 ng/mL means clear iron deficiency for most adults, as our article on the new 30 ng/mL ferritin cutoff explains. In RLS, a value between 30 and 100 ng/mL can still justify iron. If your ferritin is low, the next question is why: heavy periods, blood donation, a diet low in iron, celiac disease or bleeding from the gut. Our page on low ferritin causes and treatment covers this search. The AASM stresses that these RLS cutoffs are consensus values that have not been tested in trials, so your doctor weighs them with your symptoms.

Too much iron is harmful too, so take iron only after a blood test and recheck ferritin after treatment.

Restless leg syndrome treatment

Treatment follows three steps: remove triggers, correct iron, then add a medicine or a device if needed.

Lifestyle and home measures

Cleveland Clinic and MedlinePlus recommend regular daytime leg exercise such as walking, stretching before bed, a warm bath or leg soak, massage, hot or cold packs, a regular sleep schedule, and avoiding caffeine, alcohol and nicotine in the evening. A 2025 meta-analysis of 17 trials found that vibration and electrical stimulation clearly reduced RLS severity, while exercise, massage, acupressure and cold therapy showed trends that were not statistically significant.

Iron therapy

The AASM strongly recommends IV ferric carboxymaltose when iron status fits the thresholds above, and conditionally suggests IV ferumoxytol, IV low molecular weight iron dextran and oral ferrous sulfate. A 2026 review notes that oral iron remains an option for children and mild cases, but its effect varies because absorption is limited, and that side effects of IV iron were generally mild, such as a temporary drop in blood phosphate. Our iron-rich breakfast guide gives food ideas, although food alone rarely raises ferritin enough for RLS.

Gabapentinoids: first-line medicines

The AASM gives a strong recommendation to gabapentin enacarbil, gabapentin and pregabalin. ChEMBL lists gabapentin and pregabalin as voltage-gated calcium channel modulators that bind the alpha-2-delta-1 subunit, calming overactive nerve signals. Gabapentin enacarbil is an approved prodrug of gabapentin (first approval 2011 in ChEMBL). In trials, about 70% of patients on gabapentinoids were much or very much improved, compared with about 40% on placebo.

Dopamine agonists and augmentation

Pramipexole, ropinirole and the rotigotine patch act on dopamine receptors; ChEMBL classifies pramipexole as a D2-like dopamine receptor agonist. For years they were the usual first choice. The 2025 AASM guideline now suggests against their standard use, and against levodopa, mainly because of augmentation. They may still be used short term by people who value quick relief and accept the long-term risk. Cabergoline is strongly advised against.

Augmentation is a worsening of RLS caused by the treatment itself. The JAMA review gives an annual incidence of 7 to 10% with dopamine agonists, and the 2016 IRLSSG task force warns that even low doses can cause it. In a 2025 Spanish cohort of 93 patients with augmentation, it appeared after a mean of 6.25 years and 85% were still taking a dopamine agonist. If your RLS keeps getting worse despite higher doses, ask your doctor about augmentation. Do not stop on your own: the IRLSSG task force advises first correcting triggers such as low iron, antidepressants and antihistamines, then switching to an alpha-2-delta ligand (gabapentinoid), rotigotine or, in severe cases, an opioid, under medical supervision.

Low-dose opioids and other options

For severe RLS that does not respond, or for augmentation, the AASM conditionally suggests extended-release oxycodone and other opioids. The JAMA review cites methadone 5 to 10 mg a day; ChEMBL lists methadone as a mu opioid receptor agonist. In the US National RLS Opioid Registry (448 patients followed for 2 years), the median dose did not change, and only 8% increased by more than 25 morphine milligram equivalents. Opioids still require careful prescribing and monitoring.

The AASM also suggests dipyridamole, a drug that ChEMBL classifies as an equilibrative nucleoside transporter 1 (ENT1) inhibitor, which raises adenosine. It suggests against clonazepam, valerian, bupropion, carbamazepine and valproic acid.

Bilateral peroneal nerve stimulation

A device worn on both lower legs stimulates the peroneal nerve at high frequency, an approach called tonic motor activation (TOMAC). The AASM gives it a conditional recommendation. Cleveland Clinic describes wearing the device for 30 to 60 minutes before bed.

Pregnancy, kidney disease and children

Restless legs during pregnancy

RLS affects about one in five pregnant women in Western countries, according to the International RLS Study Group (IRLSSG) consensus. A 2023 review of sleep disorders in pregnancy reports that it peaks in the third trimester (22.9% in a meta-analysis) and usually resolves after delivery, sometimes within 2 weeks. Iron deficiency, low ferritin, low folate and low haemoglobin are linked to more severe symptoms. The IRLSSG advises reassurance, exercise, avoiding triggers and a rationale for iron when stores are low; only a few medicines are rated "may be considered", and only when RLS does not respond to conservative care. The AASM asks prescribers to consider each treatment's safety in pregnancy. Our article on blood tests during pregnancy explains when ferritin is checked.

Chronic kidney disease and dialysis

A 2023 systematic review found RLS in 15 to 30% of people on dialysis, two to three times more than in the general population, with more insomnia, depression and cardiovascular events. For dialysis patients, the AASM suggests gabapentin, IV iron sucrose when ferritin is below 200 ng/mL and TSAT below 20%, and vitamin C. Cleveland Clinic notes that a kidney transplant may make RLS go away. If you have kidney disease, your kidney function panel helps your team choose and dose treatment.

Restless legs in children

MedlinePlus Genetics estimates that RLS affects 2 to 4% of US children. Cleveland Clinic notes that it is harder to recognise because children may not be able to describe what they feel, and that it can look like ADHD or growing pains. Our guide to ADHD symptoms and diagnosis describes the overlap. The AASM suggests iron when ferritin is below 50 ng/mL, and conditionally suggests ferrous sulfate.

Prevention and long-term follow-up

MedlinePlus states that there is no known way to prevent RLS, but you can lower the chance of flares. Keep iron stores healthy, recheck ferritin and TSAT regularly once you have RLS, keep a sleep and symptom diary, and bring your list of medicines and supplements to each visit. Ask before taking a sedating antihistamine such as diphenhydramine. If you have peripheral neuropathy or diabetes, treating it can also ease RLS.

When to see a doctor

Make an appointment if the urge to move keeps you awake, if symptoms happen several times a week, if they keep getting worse while you take an RLS medicine, or if you are pregnant and sleep is suffering.

RLS itself is not an emergency. Call 999 if leg symptoms come with sudden weakness, numbness on one side of the body, loss of bladder or bowel control, or a swollen, red, painful calf (a possible blood clot), or if you have thoughts of harming yourself. The JAMA review notes a higher rate of suicidal thoughts in people with RLS.

Latest scientific advances in restless legs syndrome

The 2025 AASM guideline changes the order of treatment

Based on a systematic review of 148 studies, the AASM guideline published in January 2025 ranks gabapentinoids and IV ferric carboxymaltose as strong recommendations and moves dopamine agonists to a conditional recommendation against standard use. A 2026 review in Current Opinion in Pulmonary Medicine describes this as a reorganization of the treatment hierarchy. For you, this means that iron testing and a non-dopamine medicine are the expected starting point.

IV iron: new trials and meta-analyses

In a US multicentre randomised trial of 209 adults (Sleep, 2024), two doses of 750 mg ferric carboxymaltose reduced the IRLS severity score by 8.0 points versus 4.8 with placebo, although the second primary endpoint was not met. A 2024 meta-analysis of 7 randomised trials (537 patients) confirmed a 6-point average improvement. In people with iron deficiency anaemia, a 2023 trial showed that 1,500 mg of ferric carboxymaltose raised iron measured by MRI in deep brain areas, and a 2024 pilot found similar benefit with IV ferumoxytol and oral ferrous sulfate. A 2026 review suggests TSAT of 35% or lower may predict response better than ferritin alone. A French delayed-start trial of IV iron in drug-resistant RLS (IRON-RLS, NCT07822607) is due to start recruiting.

Tonic motor activation, a drug-free device

In the RESTFUL randomised sham-controlled trial (NCT04874155) of 133 adults whose RLS resisted medicines, 45% responded with active stimulation versus 16% with sham after 4 weeks. In the extension study (NCT05196828), the response rate reached 72.7% at 24 weeks, and benefits partly faded when the device was stopped. A 2026 individual-participant meta-analysis of 252 participants found benefit both alone and added to medicines, with mild discomfort as the only extra side effect. The THRIVE post-market study (NCT06076499, 325 participants) is following long-term results, and a small trial is testing the approach in pregnancy (NCT07144631).

Opioid safety over the long term

The National RLS Opioid Registry showed stable doses in most patients over 2 years (Neurology, 2023), and the 2026 review reports that registry data now extending to 5 years remain largely stable. This differs from the dose escalation often seen in chronic pain, and supports carefully supervised low-dose use for refractory or augmented RLS.

Which tests can help?

Ask your doctor about:

  • morning iron studies after 24 hours without iron: ferritin, serum iron, TIBC and transferrin saturation;
  • complete blood count to look for anaemia;
  • kidney function (creatinine, eGFR), since kidney failure is a common cause;
  • glucose or HbA1c, vitamin B12, folate and magnesium when neuropathy or deficiency is suspected;
  • a sleep study only if sleep apnoea or another sleep disorder is suspected.

Glossary

  • Willis-Ekbom disease: another name for restless legs syndrome.
  • Ferritin: the protein that stores iron; its blood level reflects your iron reserves.
  • Transferrin saturation (TSAT): the share of the iron transport protein carrying iron, calculated from serum iron and TIBC.
  • Augmentation: a worsening of RLS caused by its treatment, mainly dopamine agonists.
  • Gabapentinoids: gabapentin, gabapentin enacarbil and pregabalin.
  • Tonic motor activation (TOMAC): high-frequency stimulation of the peroneal nerve by a wearable device.
  • IRLS: the International RLS Study Group rating scale, used to measure severity in trials.

Frequently asked questions

What is Periodic Limb Movement Disorder (PLMD)?

PLMD is a sleep disorder in which the legs, and sometimes the arms, twitch or jerk repeatedly during sleep, as MedlinePlus explains. The Sleep Foundation adds that the movements usually come every 20 to 40 seconds, often as an upward flex of the ankle and big toe, that they affect 4 to 11% of adults, and that the diagnosis rests on a sleep study plus your symptoms. Low iron is a suspected factor here too. The AASM guideline covers both disorders and suggests against triazolam and valproic acid for PLMD.

What could be causing tingling in my legs at night?

Tingling with an urge to move that improves when you walk points to RLS. Tingling, burning or numbness that does not improve with movement suggests neuropathy, for example from diabetes or low vitamin B12; our guide to low vitamin B12 and nerve damage explains this cause. A painful hard muscle points to a cramp. A visit with blood tests (ferritin, TSAT, glucose, B12, kidney function) usually narrows it down.

What stretches can I do to help with restless legs?

Cleveland Clinic recommends stretching before bed, especially the legs, and MedlinePlus advises gentle stretches, massage and warm baths to relax the muscles. Simple calf, thigh and hamstring stretches done slowly are a good start. Regular daytime walking and a warm leg soak help too. Stretching relieves symptoms for a while but does not replace iron testing.

Does low ferritin cause restless legs?

Low iron is the most common correctable contributor. Studies link RLS to low brain iron, and RLS is about five to six times more common in iron deficiency anaemia, according to a 2024 trial report in the American Journal of Hematology. Raising ferritin often reduces symptoms, even in people who are not anaemic.

Can restless legs syndrome go away?

RLS linked to pregnancy usually disappears after delivery, and RLS caused by low iron or a medicine may improve when the cause is fixed. Primary RLS is usually lifelong, but treatment controls symptoms for most people. RLS does not shorten life expectancy, notes Cleveland Clinic.

Is magnesium good for restless legs?

MedlinePlus lists magnesium deficiency among conditions linked to RLS, so correcting a proven deficiency makes sense; see our guide to magnesium deficiency symptoms and tests. Magnesium is not among the treatments recommended by the 2025 AASM guideline.

Sources

  • Winkelman JW et al. — Treatment of restless legs syndrome and periodic limb movement disorder: an AASM clinical practice guideline — J Clin Sleep Med, 2025 — doi.org
  • Winkelman JW et al. — Treatment of RLS and PLMD: AASM systematic review, meta-analysis and GRADE assessment — J Clin Sleep Med, 2025 — doi.org
  • Winkelman JW, Wipper B — Restless Legs Syndrome: A Review — JAMA, 2026 — doi.org
  • Allen RP et al. — Evidence-based and consensus guidelines for the iron treatment of RLS/WED in adults and children: an IRLSSG task force report — Sleep Med, 2018 — doi.org
  • Earley CJ et al. — Intravenous ferric carboxymaltose for RLS: a multicenter, randomized, placebo-controlled trial — Sleep, 2024 — doi.org
  • Qadri et al. — IV ferric carboxymaltose in RLS: a meta-analysis of 537 patients — Sleep Med, 2024 — doi.org
  • Bae et al. — Ferric carboxymaltose effects on RLS and on brain iron in iron deficiency anemia — Sleep Med, 2023 — doi.org
  • Short et al. — Intravenous versus oral iron for RLS in iron deficiency anemia: a randomized pilot study — Am J Hematol, 2024 — doi.org
  • Bogan RK et al. — Tonic motor activation for medication-refractory RLS: the RESTFUL randomized trial — Sleep, 2023 — doi.org
  • Roy A et al. — Long-term tonic motor activation: a 24-week open-label extension — Sleep, 2023 — doi.org
  • Karroum et al. — TOMAC as adjunctive and monotherapy for RLS: individual participant data meta-analysis — Sleep Med, 2026 — doi.org
  • Winkelman JW et al. — Long-term safety, dose stability and efficacy of opioids in the National RLS Opioid Registry — Neurology, 2023 — doi.org
  • Berry et al. — Management of RLS when gabapentinoids fail: intravenous iron and opioids — Curr Opin Pulm Med, 2026 — doi.org
  • Martín-García R et al. — Augmentation in restless legs syndrome: a Spanish cohort — Sleep Med, 2025 — doi.org
  • Phan et al. — Iron therapy and restless legs syndrome: a narrative review — Sleep Breath, 2026 — doi.org
  • Castillo-Álvarez F, Marzo-Sola ME — Restless legs syndrome: pathophysiology, diagnosis and treatment — Med Clin (Barc), 2024 — doi.org
  • Garcia-Borreguero D et al. — First-line treatment of RLS/WED and prevention and treatment of dopaminergic augmentation: IRLSSG, EURLSSG and RLS Foundation task force — Sleep Med, 2016 — doi.org
  • Lee NH — Iron deficiency in children with a focus on inflammatory conditions — Clin Exp Pediatr, 2024 — doi.org
  • Picchietti DL et al. — Consensus guidelines for RLS/WED during pregnancy and lactation — Sleep Med Rev, 2015 — doi.org
  • Kember AJ et al. — Common sleep disorders in pregnancy: a review — Front Med, 2023 — doi.org
  • Safarpour Y et al. — Restless legs syndrome in chronic kidney disease: a systematic review — Tremor Other Hyperkinet Mov, 2023 — doi.org
  • Silvestri R, Aricò I — Mimics of childhood restless legs syndrome — Sleep Med Clin, 2025 — doi.org
  • Gupta B et al. — Vibration, electrical stimulation and other non-pharmacological interventions for RLS: meta-analysis — Ann Indian Acad Neurol, 2025 — doi.org
  • ClinicalTrials.gov — RESTFUL study of tonic motor activation — NCT04874155 — clinicaltrials.gov
  • ClinicalTrials.gov — THRIVE post-market study of TOMAC — NCT06076499 — clinicaltrials.gov
  • ClinicalTrials.gov — IRON-RLS: IV iron in drug-resistant RLS — NCT07822607 — clinicaltrials.gov
  • ClinicalTrials.gov — PENS-P: peroneal nerve stimulation in pregnancy — NCT07144631 — clinicaltrials.gov
  • MedlinePlus — Restless legs syndrome (Medical Encyclopedia) — National Library of Medicine — medlineplus.gov
  • MedlinePlus — Restless Legs (health topic) — National Library of Medicine — medlineplus.gov
  • MedlinePlus Genetics — Restless legs syndrome — National Library of Medicine — medlineplus.gov
  • Cleveland Clinic — Restless Legs Syndrome (RLS) — 2026 — clevelandclinic.org
  • Sleep Foundation — Restless Legs Syndrome — 2026 — sleepfoundation.org
  • Sleep Foundation — Periodic Limb Movement Disorder — 2026 — sleepfoundation.org
  • EMBL-EBI — ChEMBL: gabapentin, gabapentin enacarbil, pregabalin, pramipexole, ropinirole, rotigotine, methadone, dipyridamole, ferric carboxymaltose — ChEMBL — ebi.ac.uk
  • NHS — Restless legs syndrome — National Health Service — nhs.uk

Further reading

Understand your lab results with AI DiagMe

Restless legs often come down to a few numbers: ferritin, transferrin saturation, haemoglobin, kidney function and sometimes vitamin B12 or glucose. AI DiagMe reads your lab report in minutes, explains each value in plain language, shows whether your ferritin reaches the levels used in RLS care, and suggests questions to ask your doctor. Upload your lab results to AI DiagMe for a clear, personal report.

Editorial team

  • AI DiagMe

    Author

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practising hospital physicians in specialties such as haematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

    Email Website
  • Julien Priour

    Edited by

    Co-founder and CEO of AI DiagMe · Senior medical editor · HEC Paris graduate

    Julien Priour is a senior medical editor at AI DiagMe, where he oversees the editorial line and the fact-checking process. A graduate of HEC Paris, he has 3 years of experience in health publishing and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). He makes sure that every article follows current medical guidelines and is reviewed and validated by a physician from the scientific and ethics committee. He sets the sourcing standards (HAS, Ameli, INSERM…) and the review standards applied across the entire site.

    Email LinkedIn
  • Dr. Claude Tchonko

    Medically reviewed by

    Dr Claude Tchonko is a haematologist, in practice since 2013, currently working at Clinique Mas de Rochet (Castelnau-le-Lez, France). With an international background, he specialises in the management of haematological malignancies (leukemias, lymphomas, myelomas), with particular expertise in autologous stem cell transplantation, CAR-T cell therapy and the optimisation of care pathways in onco-haematology.

    Author of a reference work, ‘Lymphoid Haematological Malignancies in Mali’, he combines clinical practice with active involvement in projects developing technology solutions for healthcare.

    He holds a State Doctorate in Medicine (Faculty of Medicine of Bamako, 2006) and completed his training with a Certificate of Specialized Studies in Bioclinical Haematology (Abidjan-Cocody, 2010) and several university diplomas: a DFMS in Haematology and an inter-university diploma (DIU) in Onco-Haematological Cytogenetics (Grenoble), as well as a university diploma (DU) in major sickle cell disease (UPEC).

    Dr. Claude Tchonko LinkedIn

Related Posts

Coming soon